KING OF PRUSSIA, Pa., Nov. 12, 2012 /PRNewswire/ -- A survey conducted by CMG, an SEC registered investment advisor outside of Philadelphia, reveals that 83% of advisors are currently using tactical and alternative investments and 84% are likely to recommend them to their clients in 2013. The survey, conducted at the annual Financial Planning Association (FPA) Experience 2012 Conference in San Antonio, also revealed that less than a quarter (23%) of advisors surveyed still use the traditional 60-40 stock/bond allocation.
"The returns of many traditional investments and strategies have been volatile and disappointing for most investors," said CMG Managing Director & Head of Distribution, Michael Sciortino, Sr. "This survey shows that the advisor community is overwhelmingly embracing tactical strategies to provide investors with a smoother, steadier investment experience."
Tactical strategies are designed to create value, particularly in volatile or uncertain markets, by providing exposure to low or non-correlated assets. According to the survey, 87% of advisors now believe a portfolio constructed using both tactical and strategic allocations offers more value than a portfolio that doesn't invest in both.
"As more investors become familiar and comfortable with tactical strategies we believe the assets will grow dramatically," Mr. Sciortino added. "Advisors are extremely interested in ways of using tactical investments to successfully navigate the challenges of the investment world by utilizing liquid, transparent and cost-effective tools like ETFs and mutual funds."
Since 1992, CMG has embraced uncommon solutions – the application of tactical investments as part of a progressive diversification strategy.
The Financial Planning Association (FPA) is the largest membership organization for personal financial planning in the US and includes professionals from all backgrounds and business models.
A detailed summary of the survey findings can be found at http://www.cmgwealth.com/ri-category/news/. For a copy of the survey findings or more information on CMG, please contact Elissa Magnavita at 1.800.891.9092 ext. 144 or [email protected]